We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USCR
2351
DELISTED
U S Concrete, Inc.
USCR
| $454K | ﹤0.01% |
13,394
+2,100
| +19% | +$62.1K |
|
|
AUD
2352
DELISTED
Audacy, Inc.
AUD
| $452K | ﹤0.01% |
37,163
+1,700
| +5% | +$20.3K |
|
|
NM
2353
DELISTED
Navios Maritime Holdings Inc.
NM
| $451K | ﹤0.01% |
10,782
+600
| +6% | +$25K |
|
2354
Pacific Biosciences
PACB
$363M
| $450K | ﹤0.01% |
77,026
+10,900
| +16% | +$75.2K |
|
2355
Arrow Financial
AROW
$661M
| $449K | ﹤0.01% |
21,348
+1,034
| +5% | +$21.3K |
|
2356
BCE
BCE
$21.2B
| $449K | ﹤0.01% |
10,600
+200
| +2% | +$8.91K |
|
2357
Clean Energy Fuels
CLNE
$410M
| $449K | ﹤0.01% |
84,122
+9,400
| +13% | +$46.7K |
|
|
IXYS
2358
DELISTED
IXYS Corp
IXYS
| $449K | ﹤0.01% |
36,455
+800
| +2% | +$9.57K |
|
|
SQI
2359
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $448K | ﹤0.01% |
26,435
+4,300
| +19% | +$68.2K |
|
|
EMWP
2360
DELISTED
Eros Media World PLC
EMWP
| $447K | ﹤0.01% |
1,278
+125
| +11% | +$45.6K |
|
|
IO
2361
DELISTED
ION Geophysical Corporation
IO
| $446K | ﹤0.01% |
13,709
+747
| +6% | +$26.8K |
|
|
SGYP
2362
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $445K | ﹤0.01% |
96,238
+17,700
| +23% | +$57.6K |
|
2363
Medifast
MED
$136M
| $444K | ﹤0.01% |
14,823
+1,350
| +10% | +$42.9K |
|
|
PFC
2364
DELISTED
Premier Financial Corp. Common Stock
PFC
| $443K | ﹤0.01% |
27,000
+1,400
| +5% | +$22.7K |
|
|
CNR
2365
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $442K | ﹤0.01% |
25,568
+4,000
| +19% | +$66.7K |
|
2366
RE/MAX Holdings
RMAX
$230M
| $441K | ﹤0.01% |
13,265
+400
| +3% | +$13.6K |
|
|
TPLM
2367
DELISTED
Triangle Petroleum Corporation
TPLM
| $441K | ﹤0.01% |
87,635
+9,100
| +12% | +$46.3K |
|
2368
Artivion
AORT
$1.29B
| $440K | ﹤0.01% |
42,430
+1,900
| +5% | +$20.9K |
|
|
ISLE
2369
DELISTED
Isle of Capri Casinos Inc
ISLE
| $439K | ﹤0.01% |
31,220
+1,700
| +6% | +$19.5K |
|
2370
Quantum Corp
QMCO
$460M
| $437K | ﹤0.01% |
1,706
+160
| +10% | +$42.2K |
|
|
PSTB
2371
DELISTED
Park Sterling Corp.
PSTB
| $437K | ﹤0.01% |
61,514
+3,400
| +6% | +$23.4K |
|
2372
Stoneridge
SRI
$207M
| $436K | ﹤0.01% |
38,616
+4,500
| +13% | +$54.1K |
|
2373
Vicor
VICR
$10.1B
| $436K | ﹤0.01% |
28,704
+1,400
| +5% | +$18.1K |
|
2374
Exelixis
EXEL
$12.9B
| $435K | ﹤0.01% |
169,080
+37,300
| +28% | +$86.6K |
|
|
GLUU
2375
DELISTED
Glu Mobile Inc.
GLUU
| $432K | ﹤0.01% |
86,172
+11,400
| +15% | +$51K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.